Kitrinor Metals Inc. and Scythian Biosciences Inc. Announce Reverse Takeover Transaction and Concurrent Financing for Up to $10 Million with Strategic Lead Investment from Aphria Inc.

February 21, 2017

Responsive image

Scythian Biosciences Inc is developing a proprietary Cannabinoid (CBD) combination therapy for the prevention and treatment of concussions and traumatic brain injury

Category: General